Recruiting
Squamous cell carcinoma of the oral cavity+4
RecruitingRegistered drugNo placebo
Study on the Safety and Effectiveness of Afatinib for Fanconi Anemia Patients with Advanced Squamous Cell Carcinoma in the Oral Cavity, Oropharynx, Hypopharynx, or Larynx
Registered drugNo placebo
- Disease:Squamous cell carcinoma of the oral cavityOropharyngeal squamous cell carcinoma+3
- Substances:Afatinib
Countries:
Germany
Germany- Participants:18–64 years · 65+ years
- Substances:Afatinib
- Sponsor:Fundacio Institut De Recerca De L'Hospital De La Santa Creu I Sant Pau

